Orchestra BioMed Holdings Inc.
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | 2.7% | – | 3.3% | – | 4.8% | 15.0% | 4.8% | 4.8% | 3.8% | 5.9% | 9.8% | 31.7% | 17.4% | 5.7% | 6.9% | 22.9% | 5.1% | 5.5% | 5.7% | 0.2% | 83.6% | 28.4% | 0.7% | |
| – | – | – | 97.3% | – | 96.7% | – | 95.2% | 85.0% | 95.2% | 95.2% | 96.2% | 94.1% | 90.2% | 68.3% | 82.6% | 94.3% | 93.1% | 77.1% | 94.9% | 94.5% | 94.3% | 99.8% | 16.4% | 71.6% | 99.3% | |
| – | – | – | 232.8% | – | 274.5% | – | 401.2% | 1,254.1% | 507.2% | 683.9% | 709.1% | 928.9% | 2,042.5% | 3,248.5% | 1,469.7% | 1,430.1% | 1,174.8% | 4,336.4% | 1,553.2% | 1,657.1% | 1,629.2% | 54.4% | 14,346.4% | 18,852.3% | 197.7% | |
| – | – | – | – | – | – | – | 286.1% | 734.7% | 453.6% | 302.4% | 379.0% | 581.2% | 1,514.1% | 1,597.3% | 951.1% | 831.2% | 574.1% | 2,332.4% | 721.5% | 749.3% | 824.4% | 23.6% | 5,793.6% | 6,623.9% | 83.2% | |
| – | – | – | 395.3% | – | 425.8% | – | 687.3% | 1,988.8% | 960.8% | 986.2% | 1,088.1% | 1,510.1% | 3,556.6% | 4,832.1% | 2,408.9% | 2,261.3% | 1,748.8% | 6,668.8% | 2,274.8% | 2,406.3% | 2,453.5% | 78.0% | 20,085.5% | 25,476.1% | 280.7% | |
| – | – | – | -297.9% | – | -329.1% | – | -592.1% | -1,903.7% | -865.6% | -891.0% | -991.8% | -1,416.0% | -3,466.3% | -4,763.7% | -2,326.3% | -2,167.0% | -1,655.7% | -6,591.7% | -2,179.8% | -2,311.8% | -2,359.2% | 21.8% | -20,069.1% | -25,404.5% | -181.4% | |
| – | – | – | – | – | – | – | 27.3% | 61.3% | – | – | 30.2% | – | – | 134.0% | – | – | – | – | – | 4.3% | 59.8% | 2.5% | 746.4% | 2,009.1% | 12.1% | |
| – | – | – | -268.8% | – | -394.4% | – | -661.5% | -1,956.9% | -884.1% | -884.0% | -939.9% | -1,316.5% | -3,178.0% | -4,892.4% | -2,171.5% | -2,054.0% | -1,562.9% | -6,385.4% | -2,160.7% | -2,316.1% | -2,419.0% | 20.2% | -18,810.0% | -26,994.3% | -184.6% | |
| – | – | – | -3.3% | – | -3.5% | – | 69.4% | -29.7% | -4.6% | -6.3% | -52.0% | -99.5% | -288.3% | 1,039.3% | 5.0% | – | – | -12.1% | – | – | – | – | – | – | – | |
| – | – | – | -268.8% | – | -394.4% | – | -661.5% | -1,956.9% | -884.1% | -884.0% | -939.9% | -1,316.5% | -3,178.0% | -4,892.4% | -2,171.5% | -2,054.0% | -1,562.9% | -6,385.4% | -2,160.7% | -2,316.1% | -2,419.0% | 20.2% | -18,810.0% | -26,994.3% | -184.6% | |
| – | – | – | -294.7% | – | -390.9% | – | -628.8% | -1,883.0% | -879.4% | -877.6% | -903.6% | -1,308.5% | -3,161.1% | -4,864.9% | -2,159.5% | -2,044.5% | -1,555.2% | -6,352.2% | -2,151.2% | -2,306.5% | -2,409.6% | 22.9% | -17,981.8% | -26,885.2% | -178.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.